Carregant...

Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine

The present study investigated the immunoenhancing property of our newly designed nanovaccine, that is, its ability to induce antigen-specific immunity. This study also evaluated the synergistic effect of a novel compound PBS-44, an α-galactosylceramide analog, in boosting the immune response induce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Format: Article
Idioma:en
Publicat: Dove Medical Press 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117944/
https://ncbi.nlm.nih.gov/pubmed/27895483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S112432
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!